OpenAlex
Neoadjuvant OX40 therapy in patients with head and neck cancer induces profound changes in tumor-infiltrating lymphocytes
Work
Year: 2018
Type: article
Cites:
Cited by: 4
Related to: 10
FWCI: 0.315
Citation percentile (by year/subfield): 60.36
Subfield: Oncology
Field: Medicine
Sustainable Development Goal Good health and well-being
Open Access status: closed